Have a personal or library account? Click to login
The effect of photobiomodulation versus placebo on functional capacity and fatigability in post COVID-19 elderly Cover

The effect of photobiomodulation versus placebo on functional capacity and fatigability in post COVID-19 elderly

Open Access
|Sep 2022

Figures & Tables

Fig. 1.

Study flow chart

A comparison of the mean FSS and KATZ scores before and after treatment in the study group

Pre-treatment Mean ± SDPost-treatment Mean ± SDp% of change
FSS4.57 ± 0.263.97 ± 0.23p < 0.05*13.13%
KATZ score2.98 ± 0.793.94 ± 0.77p < 0.05*32.2 %

Comparison between groups regarding in pre – and post-treatment mean FSS and KATZ scores

PBM groupPlacebo groupBetween groups

Pre-treatment Mean ± SDPost-treatment Mean ± SDPre-treatment Mean ± SDPost-treatment Mean ± SDPre-treatmentPost-treatment
FSS4.57 ± 0.263.97 ± 0.234.62 ± 0.254.25 ± 0.26p = 0.298p < 0.05*
KATZ score2.98 ± 0.793.94 ± 0.773.04 ± 0.863.62 ± 0.86p = 0.712p = 0.071

Demographic data and physical characteristics of patients in both groups

ItemsPBM groupPlacebo groupComparison

Mean ± SDMean ± SDt-valueP-value
Age (years)63.48 ± 2.8263.62 ± 2.870.2460.807
BMI (kg/m2)27.27 ± 1.2527.44 ± 1.330.6680.506

A comparison of the pre – and post-treatment FSS and KATZ scores for the placebo group

Pre-treatment Mean ± SDPost-treatment Mean ± SDp% of change
FSS4.62 ± 0.254.25 ± 0.26p < 0.05*8.1%
KATZ score3.04 ± 0.863.62 ± 0.86p < 0.05*19.1 %
Language: English
Page range: 19 - 25
Submitted on: Mar 23, 2022
|
Accepted on: Sep 27, 2022
|
Published on: Sep 28, 2022
In partnership with: Paradigm Publishing Services

© 2022 Rana Hesham Mohamed Elbanna, Hussein Mogahed, Magda Zahran, Eman Mohamed, published by University of Physical Education in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.